United Therapeutics
UTHR
#1127
Rank
$21.40 B
Marketcap
$473.39
Share price
-1.49%
Change (1 day)
32.15%
Change (1 year)

United Therapeutics (UTHR) - P/B ratio

P/B ratio as of February 2026 : 3.25

According to United Therapeutics's latest financial reports the company has a price-to-book ratio of 6.84365.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

United Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-313.4136.69%
2024-12-312.4944.43%
2023-12-311.73-34.66%
2022-12-312.647.49%
2021-12-312.4623.72%
2020-12-311.9942.91%
2019-12-311.39-17.77%
2018-12-311.69-43.91%
2017-12-313.01-7.74%
2016-12-313.27-27.08%
2015-12-314.48-7.05%
2014-12-314.8210.33%
2013-12-314.3778.48%
2012-12-312.45-14.81%
2011-12-312.87-30.21%
2010-12-314.12-5.83%
2009-12-314.3767.09%
2008-12-312.62-64.38%
2007-12-317.3428.71%
2006-12-315.71-2.6%
2005-12-315.8610.87%
2004-12-315.2881.27%
2003-12-312.9243.21%
2002-12-312.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.63-49.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
35.9 1,004.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.82-43.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
8.75 169.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
-19.6-702.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
5.64 73.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
-15.9-590.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.04 55.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel